Revvity, Inc. (RVTY)

NYSE · Healthcare · Diagnostics & Research
$145.22-4.20%As of 2026-11-22 · USD
Last session low $143.61Last session high $150.40
52-week low $81.2252-week high $171.74
Market cap
$16.21B
Sector
Healthcare
P/E (TTM)
64.5x
Dividend yield
0.19%
Next earnings
2027-02-01 (est.)

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)41.9In the neutral range (30 to 70)
MACD (12, 26, 9)-0.83Below its signal line (0.77); histogram -1.60
Bollinger %B (20, 2)0%Inside the bands (145.12 to 167.61)
SMA 20156.37Price is 7.1% below
SMA 50152.81Price is 5.0% below
SMA 200115.17Price is 26.1% above
ATR (20)4.69% of priceAverage true range per day
52-week position71%In the upper part of the 81.22 to 171.74 range

About Revvity, Inc.

Revvity, Inc. provides health sciences solutions, technologies, and services.

Latest fiscal yearEnded 2025-12-31: revenue of $2.86B and an operating margin of 12.5%.
Next earnings reportExpected on 2027-02-01 (the date is an estimate).

More in Diagnostics & Research